Great Cancer Therapy Relies on Accurate Tumor Samples

An overview of current traditional tissue and liquid biopsy methods, with a focus on non-small cell lung cancer (NSCLC) is discussed. In order to provide the correct treatment for cancer patients, companion diagnostic tests are required by the FDA for certain medications prior to being prescribed. These tests have to be performed on a patient's tumor sample. Tissue biopsies are the gold standard method for acquiring tumor tissue, however they are highly invasive and inaccurate. Liquid biopsies are becoming more popular, but the technology still poses several limitations.

May 2, 2022

Conor Simpson
Business Development | Market Analyst
Great Cancer Therapy Relies on Accurate Tumor Samples

Collaborate with us

Ranked 1st


We’re always open to collaborations, such as our ongoing eurostarsTM project, where we were ranked 1st out of all the applications in 2019 call 1.